Sign in
CompletedNo phase

Mini-invasive Spine Surgery for Neuromuscolar Scoliosis

Key facts

Who runs it
Istituto Ortopedico Rizzoli
Where
Italy1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
1 person enrolled
Started
28 Oct 2024
Ended
31 Dec 2025
Type of study
Interventional
Treatments tested
  • mini-invasive spine surgery
Record updated
23 February 2026

Who can take part

Age
9 years to 25 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 17 criteriaShow less

Who can take part

  • Diagnosis of SNM
  • Age 9 to 25 years
  • Male and female gender
  • Preoperative Cobb > 45° COBB
  • Preoperative pelvic obliquity > 10°
  • Extent of scoliotic curve (expressed in COBB degrees) on supine whole spine X-ray; ≤ 25% compared with magnitude of curve assessed on into spinal X-rays from supine sitting
  • Loss of walking ability
  • Absence of emergency criteria for spinal surgery

Who cannot take part

  • Criteria for surgical urgency
  • Scoliosis with etiology other than SNM
  • Pre-operative Cobb < 45° COBB
  • Preoperative pelvic obliquity < 10°
  • High anesthesiologic risk for severe respiratory deficit
  • Preserved ambulatory capacity
  • Patients who did not perform follow-up at the Rizzoli Orthopaedic Institute
  • Patients whose parents/guardians have denied consent for access to their own medical records
  • Language barrier

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Neuromuscular scoliosis (SNM) are deformities related to the impairment of normal function of the central nervous system (CNS) and/or peripheral nervous system (PNS) resulting in alterations to the of the functional unit represented by the integrated motor sequence (SIM). At the level of the spine, dysfunction of the SIM results in altered dynamic support of the spine. This results in a control of the trunk that is not harmonious due to the lack of effective mechanisms of muscle compensation. In particular, a greater degree of pelvic tilt with respect to the ground plane, with an increase in the degree of the so-called pelvic obliquity (OP), a fundamental parameter in walking and maintaining the seated posture. Spinal deformity causes severe alterations of the rib cage resulting in respiratory failure that often requires ventilatory supports and is associated with frequent airway infections, including pneumonias, often fatal. SNMs also express other comorbidities: cardiac (heart failure), neurological (epilepsy), nutritional that necessitate careful management multidisciplinary and especially anesthesiological evaluation for the peri-operative management. The surgical treatment of SNM constitutes a topic that is still debated due to both the bio-mechanical peculiarities of SNM and the clinical features, particularly comorbidities, that characterize this patient population. Compared with idiopathic scoliosis surgery, in SNM there is a higher rate of complications. To date, most of the complications are respiratory in nature (23%), followed by complications mechanical of the implanted surgical instrumentation (13%), and surgical site infections (11%). Furthermore, there is evidence that SNM surgery correlates with increased blood loss intraoperative. To date, it is recognized in the literature that the safest and most effective surgical treatment for SNMs is arthrodesis posterior instrumented with pedicle screws extended to the pelvis. In the years, mini-invasive surgical techniques have become increasingly prominent. invasive with the goal of reducing operative time, blood loss and complications themselves.

The group in the trial

  • experimentalTreatment being tested

    severe neuromuscolar scoliosis who need surgical correction

    Treatment: mini-invasive spine surgery

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Mini-invasive Fusion in Spine Surgery for Neuromuscolar Scoliosis: a Pilot Study
Record updated
23 February 2026